Abstract
Vascular endothelial growth factor-A (VEGF-A) induces actin reorganization and migration of endothelial cells through a p38 mitogen-activated protein kinase (MAPK) pathway. LIM-kinase 1 (LIMK1) induces actin remodeling by phosphorylating and inactivating cofilin, an actin-depolymerizing factor. In this study, we demonstrate that activation of LIMK1 by MAPKAPK-2 (MK2; a downstream kinase of p38 MAPK) represents a novel signaling pathway in VEGF-A-induced cell migration. VEGF-A induced LIMK1 activation and cofilin phosphorylation, and this was inhibited by the p38 MAPK inhibitor SB203580. Although p38 phosphorylated LIMK1 at Ser-310, it failed to activate LIMK1 directly; however, MK2 activated LIMK1 by phosphorylation at Ser-323. Expression of a Ser-323-non-phosphorylatable mutant of LIMK1 suppressed VEGF-A-induced stress fiber formation and cell migration; however, expression of a Ser-323-phosphorylation-mimic mutant enhanced these processes. Knockdown of MK2 by siRNA suppressed VEGF-A-induced LIMK1 activation, stress fiber formation, and cell migration. Expression of kinase-dead LIMK1 suppressed VEGF-A-induced tubule formation. These findings suggest that MK2-mediated LIMK1 phosphorylation/activation plays an essential role in VEGF-A-induced actin reorganization, migration, and tubule formation of endothelial cells.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Actins / metabolism
-
Amino Acid Substitution
-
Cell Movement / drug effects
-
Cell Movement / physiology*
-
Cofilin 1 / metabolism
-
Endothelial Cells / cytology
-
Endothelial Cells / enzymology*
-
Enzyme Inhibitors / pharmacology
-
Humans
-
Imidazoles / pharmacology
-
Intracellular Signaling Peptides and Proteins
-
Lim Kinases
-
MAP Kinase Signaling System / drug effects
-
MAP Kinase Signaling System / physiology*
-
Mutagenesis, Site-Directed
-
Phosphorylation / drug effects
-
Point Mutation
-
Protein Kinases / genetics
-
Protein Kinases / metabolism
-
Protein Processing, Post-Translational / drug effects
-
Protein Processing, Post-Translational / physiology
-
Protein Serine-Threonine Kinases
-
Pyridines / pharmacology
-
RNA, Small Interfering / genetics
-
Tubulin / metabolism
-
Vascular Endothelial Growth Factor A / metabolism*
-
Vascular Endothelial Growth Factor A / pharmacology
-
p38 Mitogen-Activated Protein Kinases / antagonists & inhibitors
-
p38 Mitogen-Activated Protein Kinases / metabolism
Substances
-
Actins
-
Cofilin 1
-
Enzyme Inhibitors
-
Imidazoles
-
Intracellular Signaling Peptides and Proteins
-
Pyridines
-
RNA, Small Interfering
-
Tubulin
-
VEGFA protein, human
-
Vascular Endothelial Growth Factor A
-
Protein Kinases
-
MAP-kinase-activated kinase 2
-
LIMK1 protein, human
-
Lim Kinases
-
Protein Serine-Threonine Kinases
-
p38 Mitogen-Activated Protein Kinases
-
SB 203580